Compile Data Set for Download or QSAR
Report error Found 191 Enz. Inhib. hit(s) with all data for entry = 10601
TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553962(US11325906, Example 25)
Affinity DataIC50: 2nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553943(US11325906, Example 7)
Affinity DataIC50: 2nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553941(US11325906, Example 5)
Affinity DataIC50: 2nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553967(US11325906, Example 30)
Affinity DataIC50: 3nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553942(US11325906, Example 6)
Affinity DataIC50: 3nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553937(US11325906, Example 1)
Affinity DataIC50: 3nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553961(US11325906, Example 24)
Affinity DataIC50: 3nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553969(US11325906, Example 32)
Affinity DataIC50: 3nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553944(US11325906, Example 8)
Affinity DataIC50: 3nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553951(US11325906, Example 14)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553948(US11325906, Example 12)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553960(US11325906, Example 23)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553940(US11325906, Example 4)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553958(US11325906, Example 21)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553966(US11325906, Example 29)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553938(US11325906, Example 2)
Affinity DataIC50: 4nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553947(US11325906, Example 11)
Affinity DataIC50: 5nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553939(US11325906, Example 3)
Affinity DataIC50: 5nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553968(US11325906, Example 31)
Affinity DataIC50: 5nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553963(US11325906, Example 26)
Affinity DataIC50: 5nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553946(US11325906, Example 10)
Affinity DataIC50: 5nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553959(US11325906, Example 22)
Affinity DataIC50: 6nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553965(US11325906, Example 28)
Affinity DataIC50: 6nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553964(US11325906, Example 27)
Affinity DataIC50: 7nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553954(US11325906, Example 17)
Affinity DataIC50: 7nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553950(US11325906, Example 13)
Affinity DataIC50: 7nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553953(US11325906, Example 16)
Affinity DataIC50: 7nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553945(US11325906, Example 9)
Affinity DataIC50: 9nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553952(US11325906, Example 15)
Affinity DataIC50: 11nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553957(US11325906, Example 20)
Affinity DataIC50: 14nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553956(US11325906, Example 19)
Affinity DataIC50: 15nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM553955(US11325906, Example 18)
Affinity DataIC50: 31nMAssay Description:PARP1: Recombinant full length 6HIS tagged PARP1 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553941(US11325906, Example 5)
Affinity DataIC50: 650nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553942(US11325906, Example 6)
Affinity DataIC50: 840nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553938(US11325906, Example 2)
Affinity DataIC50: 880nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553959(US11325906, Example 22)
Affinity DataIC50: 1.00E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553939(US11325906, Example 3)
Affinity DataIC50: 1.30E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553943(US11325906, Example 7)
Affinity DataIC50: 1.30E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553940(US11325906, Example 4)
Affinity DataIC50: 1.50E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553948(US11325906, Example 12)
Affinity DataIC50: 1.60E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553937(US11325906, Example 1)
Affinity DataIC50: 1.70E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553954(US11325906, Example 17)
Affinity DataIC50: 1.70E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetProtein mono-ADP-ribosyltransferase PARP3(Human)
Astrazeneca

US Patent
LigandPNGBDBM553969(US11325906, Example 32)
Affinity DataIC50: 1.90E+3nMAssay Description:PARP3: Recombinant full length PARP3 protein was diluted to 100 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553969(US11325906, Example 32)
Affinity DataIC50: 2.10E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetProtein mono-ADP-ribosyltransferase PARP3(Human)
Astrazeneca

US Patent
LigandPNGBDBM553959(US11325906, Example 22)
Affinity DataIC50: 2.60E+3nMAssay Description:PARP3: Recombinant full length PARP3 protein was diluted to 100 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetProtein mono-ADP-ribosyltransferase PARP3(Human)
Astrazeneca

US Patent
LigandPNGBDBM553968(US11325906, Example 31)
Affinity DataIC50: 2.60E+3nMAssay Description:PARP3: Recombinant full length PARP3 protein was diluted to 100 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetProtein mono-ADP-ribosyltransferase PARP3(Human)
Astrazeneca

US Patent
LigandPNGBDBM553943(US11325906, Example 7)
Affinity DataIC50: 2.60E+3nMAssay Description:PARP3: Recombinant full length PARP3 protein was diluted to 100 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553951(US11325906, Example 14)
Affinity DataIC50: 2.90E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553953(US11325906, Example 16)
Affinity DataIC50: 3.30E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM553952(US11325906, Example 15)
Affinity DataIC50: 3.60E+3nMAssay Description:PARP2: Recombinant full length PARP2 protein was diluted to 6 nM with 50 mM Tris pH 8, 0.001% Triton X100, 10 mM MgCl2, 150 mM NaCl and incubated for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
US Patent

Displayed 1 to 50 (of 191 total ) | Next | Last >>
Jump to: